- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07349134
WELL-MPN : Une application de mode de vie numérique pour les patients atteints de néoplasmes myéloprolifératifs (NMP) (WELL-MPN)
Essai Pilote Contrôlé Randomisé d'une Intervention Numérique pour Promouvoir le Bien-être, l'Autonomisation et l'Apprentissage du Mode de Vie pour les Patients Atteints de Néoplasmes Myéloprolifératifs (WELL-MPN)
The goal of this clinical trial is to learn whether a digital lifestyle app can help improve diet, physical activity, symptoms, emotional well-being, and quality of life in adults with myeloproliferative neoplasms (MPNs).
The main questions it aims to answer are:
Can people with MPNs use the WELL-MPN app?
Does using the WELL-MPN app improve diet quality and physical activity?
Does the WELL-MPN app improve MPN-related symptoms, anxiety and depression, confidence in managing health, and overall quality of life?
Researchers will compare participants who use the WELL-MPN digital app with participants who receive written educational materials about diet and physical activity for people with cancer to see if the app leads to greater improvements in lifestyle behaviors, symptoms, and well-being.
Participants will:
Be randomly assigned to use the WELL-MPN app or receive written lifestyle education materials
Use the assigned program or materials over the study period
Complete surveys about diet, physical activity, symptoms, mood, confidence in self-care, and quality of life
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: Chi-Joan How
- Numéro de téléphone: 617-732-5190
- E-mail: jhow@bwh.harvard.edu
Lieux d'étude
-
-
Massachusetts
-
Boston, Massachusetts, États-Unis, 02115
- Mass General Brigham
-
Contact:
- Chi-Joan How
- Numéro de téléphone: 6177325190
- E-mail: jhow@bwh.harvard.edu
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Diagnosed with a myeloproliferative neoplasm (MPN) by World Health Organization 2016 criteria
- Adult (age >/= 18)
- Able to comprehend and speak English
- Able to provide informed consent
Exclusion Criteria:
- Unable to comprehend and speak English
- Unable to provide informed consent
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Soins de soutien
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: WELL-MPN Digital App
WELL-MPN app and usual care |
Patients randomized to the WELL-MPN arm will be given access to the WELL-MPN digital program (app) which provides lifestyle counseling through an iPad. |
|
Aucune intervention: Enhanced Usual Care
Usual care and written literature about diet and physical activity guidelines in patients with cancer |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Number of patients consented and enrolled onto the study, and number of patients who complete at least 2 out of 3 modules in the app.
Délai: 2 years
|
Primary outcome is feasibility, defined as ≥60% enrollment of eligible patients and ≥70% of patients randomized to the intervention group completing at least 2 out of 3 of app modules. |
2 years
|
|
8-Item Client Satisfaction Scores (CSQ-8)
Délai: Enrollment to 16 weeks after enrollment
|
Acceptability of WELL-MPN as measured by CSQ-8 scores of WELL-MPN. The CSQ-8 is a self-report tool designed to measure patient satisfaction with a received intervention. It consists of 8 items rated on a 4-point Likert scale (from "quite dissatisfied" to "very satisfied"), with higher scores indicating greater satisfaction. WELL-MPN is considered acceptable if >80% of participants on the WELL-MPN arm report a CSQ-8 score >20. |
Enrollment to 16 weeks after enrollment
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Healthy Eating Index calculated from the Automated Self-Administered Dietary Assessment Tool
Délai: Enrollment to 16 weeks after enrollment.
|
Diet quality will be compared between control and WELL-MPN patients. The ASA24 is a free 24-hour dietary recall tool developed by the National Cancer Institute. Responses will be used to calculate a Healthy Eating Index (HEI) score, which is a measure of dietary quality that addresses compliance with the 2015 United States Department of Agriculture dietary guidelines (scores range from 0 to 100, with higher scores indicating greater alignment with dietary guidelines). |
Enrollment to 16 weeks after enrollment.
|
|
Mini Eating Assessment Tool (Mini-EAT) score
Délai: Enrollment to 16 weeks after enrollment.
|
Diet quality will be compared between control and WELL-MPN patients. The Mini-EAT is a 9-item validated brief dietary screener designed for greater ease of administration compared to the ASA-24 but has strong correlation with the HEI. Responses generate a score ranging from 0 to 54, with higher scores reflecting greater adherence to healthy dietary patterns aligned with the Dietary Guidelines for Americans. |
Enrollment to 16 weeks after enrollment.
|
|
Godin Leisure Time Exercise Questionnaire
Délai: Enrollment to 16 weeks after enrollment.
|
Physical activity will be compared between control and WELL-MPN patients. The Godin Leisure Time Exercise Questionnaire is a brief, self-reported tool used to assess a person's usual physical activity during their free time.It consists of three questions asking information on the number of times one engages in mild, moderate, and strenuous physical activity of at least 15-minute durations in a typical week. Higher scores indicate greater physical activity, with scores of less than 14 units indicating insufficient / sedentary activity. |
Enrollment to 16 weeks after enrollment.
|
|
Patient-Reported Outcomes Measurement Information System (PROMIS) Self-Efficacy Short Forms
Délai: Enrollment to 16 weeks after enrollment.
|
Self-efficacy will be compared between control and WELL-MPN patients. The PROMIS Self-Efficacy Short Forms include 4-item scales across domains such as managing daily activities, symptoms, medications, emotions, and social interactions. Each item is rated on a 5-point Likert scale, with higher scores indicating greater self-efficacy. |
Enrollment to 16 weeks after enrollment.
|
|
MPN Symptom Assessment Form (SAF) Total Symptom Score (TSS)
Délai: Enrollment to 16 weeks after enrollment.
|
MPN symptom scores will be compared between control and WELL-MPN patients. The MPN SAF TSS is a 10-item questionnaire assessing the most representative and clinically relevant MPN symptoms (concentration, early satiety, inactivity, night sweats, itching, bone pain, abdominal discomfort, weight loss, fever), and includes a "worst fatigue" question from the Brief Fatigue Inventory. Each subscale ranges from 0 (absent / as good as it can be) to 10 (worst imaginable / as bad as it can be), and scores are computed as the average of the observed items multiplied by 10 to achieve a 0 to 100 scale. |
Enrollment to 16 weeks after enrollment.
|
|
Hospital Anxiety and Depression Scale (HADS-A and HADS-D):
Délai: Enrollment to 16 weeks after enrollment.
|
Psychological distress will be compared between controls and WELL-MPN patients. The 14-item HADS consists of two 7-item subscales assessing anxiety and depression symptoms in the past week. Each subscale ranges from 0 (no distress) to 21 (maximum distress), with higher scores indicating worse distress. Subscale scores > 8 indicate clinically significant distress; scores can be further interpreted as follows: 8-10 indicates mild distress, 11-14 indicates moderate distress, and 15-21 indicates severe distress. |
Enrollment to 16 weeks after enrollment.
|
|
Functional Assessment of Cancer - General (FACT-G)
Délai: Enrollment to 16 weeks after enrollment.
|
Quality of life will be compared between controls and WELL-MPN patients. The FACT-G consists of four subscales assessing well-being across four domains (physical, functional, emotional, and social). Subscale scores include Functional Well-Being (0-28), Social Well-Being (0-28), Emotional Well-Being (0-24), and Functional Well-Being (0-28) with higher scores reflecting better well-being in each domain. |
Enrollment to 16 weeks after enrollment.
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Chi-Joan How, Massachusetts General Hospital
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Estimé)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
- Tumeurs par site
- Tumeurs
- Maladies hématologiques
- Troubles de la coagulation sanguine
- Maladies de la moelle osseuse
- Troubles hémorragiques
- Troubles des plaquettes sanguines
- Tumeurs de la moelle osseuse
- Tumeurs hématologiques
- Maladies hémiques et lymphatiques
- Thrombocytose
- Troubles myéloprolifératifs
- Thrombocytémie essentielle
- Polyglobulie Vera
- Myélofibrose primaire
Autres numéros d'identification d'étude
- 25-805
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .